ExonHit wants co-developer for Alzheimer's drug

03/4/2009 | Reuters

ExonHit Therapeutics, a French drug and diagnostics company, is searching for a partner to develop EHT 0202, its drug for Alzheimer's disease, upon the conclusion of Phase II studies in the final quarter of this year. The move comes as ExonHit prepares to launch its Alzheimer's diagnostic test in the second half of this year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC